# Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/myocardial-viability-as-a-determinant-of-the-ejection-fraction-response-to/

## Facts

| Field | Value |
| --- | --- |
| Author Names | JGF Cleland,Dudley J. Pennell,SG Ray,Andrew J.S. Coats,P. W. Macfarlane,Gordon Murray,J Dalle Mule,Zvi Vered,Avijit Lahiri |
| Citations | 301 |
| DOI | 10.1016/s0140-6736(03)13801-9 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1998658944 |
| PMID | 12853194 |
| Type | article |
| Year | 2003 |

## Paper authors

- [Avijit Lahiri](https://scholariq.org/researchers/avijit-lahiri/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)

## Paper topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.